棕榈酸帕利哌酮与利培酮长效注射剂治疗精神分裂症有效性和安全性的Meta分析OA
The Efficacy and Safety of Paliperidone Palmitate Long-acting Injection and Risperidone Long-acting Injection for Schizophrenia:A Meta-analysis
目的 评价棕榈酸帕利哌酮注射剂(PP-LAI)和利培酮长效注射剂(RLAI)治疗精神分裂症的有效性和安全性.方法 检索中国期刊全文数据库、中文期刊全文数据库、万方数据知识服务平台、PubMed和The Cochrane library等中英文数据库中关于PP-LAI和RLAI的临床随机对照试验,通过The Cochrane评分工具评估文献质量,再利用RevMan 5.4 软件对数据进行Meta分析,从而比较两种药物治疗精神分裂症的有效性与安全性差…查看全部>>
Objective To evaluate the efficacy and safety of Paliperidone Palmitate Long-Acting Injection(PP-LAI)and Risperidone Long-acting Injection(RLAI)for schizophrenia.Methods Databases including CNKI,VIP,PubMed,and The Cochrane Library were searched to collect Randomized Controlled Trials(RCTs)on PP-LAI and RLAI.The Cochrane Collaboration's tool was used to access the risk of bias,and RevMan 5.4 was used for meta-analysis,to compare the differences between the tw…查看全部>>
杨越茗;刘永军
中国药科大学国际医药商学院,南京 211198中国药科大学国际医药商学院,南京 211198
临床医学
棕榈酸帕利哌酮利培酮精神分裂症Meta分析
Paliperidone PalmitateRisperidoneSchizophreniaMeta-analysis
《中国药物经济学》 2023 (11)
32-38,42,8
评论